Interaction between NG2 proteoglycan and PDGF α-receptor on O2A progenitor cells is required for optimal response to PDGF

Journal of Neuroscience Research

Volumn 43, Issue 3, 1996, Pages 315-330

  Nishiyama, A ^a,d   Lin, X H ^a   Giese, N ^b   Heldin, C H ^c   Stallcup, W B ^a  

^a BURNHAM INSTITUTE   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

growth factor signalling; NG2 chondroitin sulfate proteoglycan; O2A glial progenitor cells; PDGF receptor; primary cell culture

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL SURFACE RECEPTOR; CHONDROITIN SULFATE; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEOGLYCAN;

ARTICLE; ASTROCYTE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DEMYELINATING DISEASE; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA CELL; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; OLIGODENDROGLIA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; REMYELINIZATION; STEM CELL;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; ANTIGENS; CELL LINE; CELLS, CULTURED; EMBRYO; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KINETICS; OLIGODENDROGLIA; OSTEOSARCOMA; PHENOTYPE; PLATELET-DERIVED GROWTH FACTOR; PROTEOGLYCANS; RATS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; STEM CELLS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0030039241     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.0.CO;2-M     Document Type: Article

References (47)

1. Barres BA, Hart IK, Coles HSR, Burne JF, Voyvodic JT, Richardson WD, Raff MC (1992): Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
2. Behar T, McMorris FA, Novotny EA, Barker JL, Dubois-Dalcq M (1988): Growth and differentiation properties of O-2A progenitors purified from rat cerebral hemispheres. J Neurosci Res 21:168-180.
3. Bottenstein J, Sato G (1979): Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76:514-517.
4. Bogler O, Wren D, Barnett SC, Land H, Noble M (1990): Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2-astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA 87:6368-6372.
5. Bogler O, Noble M (1994): Measurement of time in oligodendrocyte-type-2 astrocyte (O-2A) progenitors is a cellular process distinct from differentiation or division. Dev Biol 162:525-538.
6. Collarini EJ, Kubn R, Marshall CJ, Monuki ES, Lemke G, Richardson WD (1992): Down-regulation of the POU transcription factor SCIP is an early event in oligodendrocyte differentiation in vitro. Development 116:193-200.
7. Eccleston PA, Silberberg DH (1985): Fibroblast growth factor is a mitogen for oligodendrocytes in vitro. Dev Brain Res 21:315-318.
8. Eisenbarth G, Walsh FS, Nirenberg M (1979): Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci USA 76:4913-4917.
9. Eriksson A, Siegbahn A, Westermark B, Heldin C-H, Claesson-Welsh L (1992): PDGF α- and β-receptors activate unique and common signal transduction pathways. The EMBO J 11:543-550.
10. Ffrench-Constant C, Raff MC (1986): The oligodendrocyte-type-2 astrocyte cell lineage is specialized for myelination Nature 322: 335-338.
11. Fretto LJ, Snape AJ, Tomlinson JE, Scroogy JJ, Wolf DL, La Rochelle WJ, Giese NA (1993): Mechanism of platelet-derived growth factor (PDGF) AA, AB, and BB binding to α and β PDGF receptors. J Biol Chem 268:3625-3631.
12. -) under different mitogenic control Neuron 5:615-625.
13. - oligodendrocyte progenitors. Dev Biol 159:618-630.
14. Grako K, Stallcup WB (1995): Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. Exp Cell Res 221:231-240.
15. Hart IK, Richardson WD, Heldin C-H, Westermark B, Raff MC (1989a): PDGF receptors on cells of the oligodendrocyte-type-2-astrocyte (O-2A) cell lineage. Development 105:595-603.
16. Hart IK, Richardson WD, Bolsover ST, Raff MC (1989b): PDGF and intracellular signaling in the timing of oligodendrocyte differentiation. J Cell Biol 109:3411-3417.
17. Hart IK, Richardson WD, Raff MC (1992): PDGF increases the expression of Fos and Jun in newly formed oligodendrocytes that have become resistant to the mitogenic effect of PDGF. Glia 6:310-313.
18. Hubbard A, Cohn Z (1972): The enzymatic iodination of the red cell membrane. J Cell Biol 55:390-415.
19. Levi G, Aloisi F, Wilkins G (1987): Differentiation of cerebellar bipotential glial precursors into oligodendrocytes in primary culture: developmental profile of surface antigens and mitotic activity. J Neurosci Res 18:407-417.
20. Levine JM, Stallcup WB (1987): Plasticity of developing cerebellar cells in vitro studied with antibodies against the NG2 antigen. J Neurosci 7:2721-2731.
21. Levine JM, Stincone F, Lee Y-S (1993): Development and differentiation of glial precursor cells in the rat cerebellum Glia 7:307-321.
22. Lopez-Casillas F, Wrana JL, Massague J (1993): Betaglycan presents ligand to the TGFβ signaling receptor. Cell 73:1435-1444.
23. McCarthy KD, de Vellis J (1980): Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
24. McKinnon R, Matsui T, Dubois-Dalcq M, Aaronson SA (1990): FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5:603-614.
25. McKinnon RD, Smith C, Behar T, Smith T, Dubois-Dalcq M, (1993): Distinct effects of bFGF and PDGF on oligodendrocyte progenitor cells. Glia 7:245-254.
26. Moustakas A, Lin HY, Henis YL Plamondon J, O'Conner-McCourt MD, Lodish HF (1993): The transforming growth factor β receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand. J Biol Chem 268:22215-22218.
27. Nishiyama A, Dahlin KJ, Price JT, Johnstone SR, Stallcup WB (1991a): The primary structure of NG2, a novel membrane-spanning proteoglycan. J Cell Biol 114:359-371.
28. Nishiyama A, Dahlin KJ, Stallcup WB (1991b): The expression of NG2 proteoglycan in the developing rat limb. Development 111.933-944.
29. Nishiyama A, Stallcup WB (1993): Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface. Mol Biol Cell 4:1097-1108.
30. Nishiyama A, Lin XH, Giese N, Heldin C-H, Stallcup WB (1996): Co-localization of NG2 proteoglycan and PDGF α-receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res 43.299-314.
31. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P (1988): Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/ type-2 astrocyte progenitor cell. J Nature 333:560-562.
32. Pringle N, Collarini EJ, Mosley MJ, Heldin C-H, Westermark B, Richardson WD (1989): PDGF A chain homodimers drive proliferation of bipotential (O-2A) glial progenitor cells in the developing rat optic nerve. EMBO J. 8. 1049-1056.
33. Raff M, Mirsky R, Fields K, Lisak R, Dorfman S, Silberberg D, Gregson N, Leibowitz S, Kennedy M (1978): Galactocerebroside is a specific antigenic marker for oligodendrocytes in culture. Nature 277:813-816.
34. Raff MC, Miller RH, Noble M (1983): A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303:390-396.
35. Raff M, Williams B, Miller R (1984): The in vitro differentiation of a bipotential glial progenitor cell. EMBO J 3:1857-1864.
36. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD (1988): Platelet-derived growth factor from astrocytes drives the clock that times oligdodendrocyte development in culture. Nature 333:562-565.
37. Raff M (1989): Glial cell diversification in the rat optic nerve. Science 243:1450-1455.
38. Ranscht B, Clapshaw PA, Price J, Noble M, Seifert W (1982): Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci U S A 79:2709-2713.
39. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M (1988): A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53:309-319.
40. Saneto RP, de Vellis J (1985): Characterization of cultured rat oligo-dendrocytes proliferating in a serum-free, chemically defined medium. Proc Natl Acad Sci U S A 82:3509-3513.
41. Sommer I, Schachner M (1981): Monoclonal antibodies (O1 and O4) to oligodendrocyte surfaces: An immunocytological study in the central nervous system. Dev Biol 83:311-327.
42. Stallcup WB, Beasley L, Levine J (1983): Cell-surface molecules that characterize different stages in the development of cerebellar interneurons. Cold Spring Harbor Symp Quant Biol 48:761-774.
43. Stallcup WB, Beasley L (1987): Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan. J Neurosci 7:2737-2744.
44. Stallcup WB, Dahlin K, Healy P (1990): Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen. J Cell Biol 111:3177-3188.
45. Tiesman J, Hart CE (1993): Identification of a soluble receptor for platelet-derived growth factor in cell-conditioned medium and human plasma. J Biol Chem 268:9621-9628.
46. Wolswijk G, Noble M (1989): Identification of an adult-specific glial progenitor cell. Development 105:387-400.
47. Yeh H-J, Ruit KG, Wang Y-X, Parks WC, Snider WD, Deuel TF (1991): PDGF A-chain gene is expressed by mammalian neurons during development and in maturity. Cell 64:209-216.